CorMedix Inc (CRMD) poses a Brand-New Opportunity for Investors with beta value of 1.36

Sana Meer

Witnessing the stock’s movement on the chart, on Thursday, CorMedix Inc (NASDAQ: CRMD) had a quiet start as it plunged -6.81% to $11.63, before settling in for the price of $12.48 at the close. Taking a more long-term approach, CRMD posted a 52-week range of $5.60-$17.43.

In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 29.80%. Meanwhile, its Annual Earning per share during the time was 29.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1006.29%. This publicly-traded company’s shares outstanding now amounts to $78.35 million, simultaneously with a float of $69.21 million. The organization now has a market capitalization sitting at $916.32 million. At the time of writing, stock’s 50-day Moving Average stood at $11.09, while the 200-day Moving Average is $11.27.

CorMedix Inc (CRMD) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. CorMedix Inc’s current insider ownership accounts for 12.15%, in contrast to 56.57% institutional ownership. Preceding that transaction, on Dec 18 ’25, Company’s Chief Executive Officer sold 30,000 for 12.00, making the whole transaction’s value amount to 360,000. This particular insider is now the holder of 509,496 in total.

CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators

Let’s observe the current performance indicators for CorMedix Inc (CRMD). It’s Quick Ratio in the last reported quarter now stands at 1.73. Alongside those numbers, its PE Ratio stands at $5.66, and its Beta score is 1.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.28. Similarly, its price to free cash flow for trailing twelve months is now 12.31.

In the same vein, CRMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.05, a figure that is expected to reach 0.84 in the next quarter, and analysts are predicting that it will be 2.54 at the market close of one year from today.

Technical Analysis of CorMedix Inc (CRMD)

Going through the that latest performance of [CorMedix Inc, CRMD]. Its last 5-days volume of 2.19 million was inferior to the volume of 2.37 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 56.62% While, its Average True Range was 46.79.

Raw Stochastic average of CorMedix Inc (CRMD) in the period of the previous 100 days is set at 42.19%, which indicates a major rise in contrast to 29.80% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.48 that was lower than 0.61 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.